Abeer H. Elmaidomy

Dr. Abeer H. Elmaidomy

Lecterure, Pharmacognosy department, Faculty of pharmacy, Beni-Suef University
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
TATarfah Al-Warhi
Tarfah Al-Warhi
Eman Maher ZahranEman Maher Zahran
Eman Maher Zahran
Samy SelimSamy Selim
Samy Selim
MAMohammad Alsanea
Mohammad Alsanea
MGMohammed M. Ghoneim
Mohammed M. Ghoneim
Abeer H. ElmaidomyAbeer H. Elmaidomy
Abeer H. Elmaidomy
This study explored the in vivo wound healing potential of Vitis vinifera seed extract using an excision wound model with focus on wound healing molecular targets including TGFBR1, VEGF, TNF-α, and IL-1β. The wound healing results revealed that V. vinifera seed extract enhanced wound closure rates (p < 0.001), elevated TGF-β and VEGF levels, and significantly downregulated TNF-α and IL-1β levels in comparison to the Mebo®-treated group. The phenotypical results were supported by biochemical and histopathological findings. Phytochemical investigation yielded a total of 36 compounds including twenty-seven compounds (1–27) identified from seed oil using GC-MS analysis, along with nine isolated compounds. Among the isolated compounds, one new benzofuran dimer (28) along with eight known ones (29–36) were identified. The structure of new compound was elucidated utilizing 1D/2D NMR, with HRESIMS analyses. Moreover, molecular docking experiments were performed to elucidate the molecular targets (TNF-α, TGFBR1, and IL-1β) of the observed wound healing activity. Additionally, the in vitro antioxidant activity of V. vinifera seed extract along with two isolated compounds (ursolic acid 34, and β-sitosterol-3-O-glucopyranoside 36) were explored. Our study highlights the potential of V. vinifera seed extract in wound repair uncovering the most probable mechanisms of action using in silico analysis.

17 April 2025 in Frontiers in Natural Products
Verified
Journal Article
Open access
PDF file
Usama AbdelmohsenUsama Abdelmohsen
Usama Abdelmohsen
Abeer H. ElmaidomyAbeer H. Elmaidomy
Abeer H. Elmaidomy
Essential oils (EOs) have a long-standing tradition and remain widely used in therapeutic applications. Their biological activities are primarily driven by complex interactions among their diverse components which exhibit synergistic or antagonistic effects, resulting in a broad spectrum of pharmacological and biological properties. These components are characterized by distinct molecular formulas, specific molecular weights, and unique physicochemical properties. The composition, content, and bioactivity of EOs are influenced by a variety of internal and external factors. Internal factors include genetic aspects (species, ecotype, chemotype, cultivar, and variety), plant developmental stage, and the specific plant part used. External factors encompass environmental and cultivation conditions (climate, radiation, diurnal and annual rhythms, harvesting practices, latitude, planting dates, irrigation, fertilization, salinity, and growth retardants), postharvest techniques (drying methods and storage conditions), and extraction and distillation processes (methods, moisture, acidity, distillation time, and gas chromatography analysis conditions). Additionally, oil degradation during storage (due to light, temperature, oxygen, chemical composition, and metal contaminants) and factors affecting bioactivity (plant part treated, solvent/detergent used, composition–activity relationships, techniques, biological material, dose/concentration selection, reference compounds, and comparison with literature data) play critical roles in shaping EO properties. This review provides a comprehensive examination of these factors, highlighting their impact on the content, composition, and bioactivity of EOs. By addressing these parameters in detail, this work aims to enhance the understanding of EOs and their therapeutic potential.

31 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Abeer H. ElmaidomyAbeer H. Elmaidomy
Abeer H. Elmaidomy
Eman Maher ZahranEman Maher Zahran
Eman Maher Zahran
RSRaya Soltan
Raya Soltan
AAahlam alasiri
ahlam alasiri
HSHani Saber
Hani Saber
Usama AbdelmohsenUsama Abdelmohsen
Usama Abdelmohsen
Malaria is one of the most important infectious diseases worldwide. The causative of the most severe forms of malaria, Plasmodium falciparum, has developed resistances against all the available antimalarial drugs. In the present study, the phytochemical investigation of the green seaweed Halimeda macroloba has afforded two new compounds 1–2, along with 4 known ones 3–6. The structures of the compounds had been confirmed using 1& 2D-NMR and HRESIMS analyses. Extensive machine-learning-supported virtual-screening suggested cytochrome-C enzyme as a potential target for compound 2. Docking, absolute-binding-free-energy (ΔGbinding) and molecular-dynamics-simulation (MDS) of compound 2 revealed the strong binding interaction of this compound with cytochrome-C. In vitro testing for crude extract and isolated compounds revealed the potential in vitro inhibitory activity of both extract and compound 2 against P. falciparum. The crude extract was able to inhibit the parasite growth with an IC50 value of 1.8 ± 0.35 µg/mL. Compound 2 also showed good inhibitory activity with an IC50 value of 3.2 ± 0.23 µg/mL. Meanwhile, compound 6 showed moderate inhibitory activity with an IC50 value of 19.3 ± 0.51 µg/mL. Accordingly, the scaffold of compound 2 can be considered as a good lead compound for the future development of new antimalarial agents.

10 April 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
SASami Alzarea
Sami Alzarea
Abeer H. ElmaidomyAbeer H. Elmaidomy
Abeer H. Elmaidomy
HSHani Saber
Hani Saber
AMARAFA MUSA
ARAFA MUSA
MAMohammad Alsanea
Mohammad Alsanea
Usama AbdelmohsenUsama Abdelmohsen
Usama Abdelmohsen
LC-MS-assisted metabolomic profiling of the Red Sea-derived brown algae Sargassum cinereum “Sargassaceae” dereplicated eleven compounds 1–11. Further phytochemical investigation afforded two new aryl cresol 12–13, along with eight known compounds 14–21. Both new metabolites, along with 19, showed moderate in vitro antiproliferative activity against HepG2, MCF-7, and Caco-2. Pharmacophore-based virtual screening suggested both 5-LOX and 15-LOX as the most probable target linked to their observed antiproliferative activity. The in vitro enzyme assays revealed 12 and 13 were able to inhibit 5-LOX more preferentially than 15-LOX, while 19 showed a convergent inhibitory activity toward both enzymes. Further in-depth in silico investigation revealed the molecular interactions inside both enzymes’ active sites and explained the varying inhibitory activity for 12 and 13 toward 5-LOX and 15-LOX.

23 May 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
Yara ShamikhYara Shamikh
Yara Shamikh
ASAliaa A. El Shamy
Aliaa A. El Shamy
Yasser GaberYasser Gaber
Yasser Gaber
Usama AbdelmohsenUsama Abdelmohsen
Usama Abdelmohsen
HMHashem A. Madkour
Hashem A. Madkour
WHWael N. Hozzein
Wael N. Hozzein
The diversity of actinomycetes associated with the marine sponge Coscinoderma mathewsi collected from Hurghada (Egypt) was studied. Twenty-three actinomycetes were separated and identified based on the 16S rDNA gene sequence analysis. Out of them, three isolates were classified as novel species of the genera Micromonospora, Nocardia, and Gordonia. Genome sequencing of actinomycete strains has revealed many silent biosynthetic gene clusters and has shown their exceptional capacity for the production of secondary metabolites, not observed under classical cultivation conditions. Therefore, the effect of mycolic-acid-containing bacteria or mycolic acid on the biosynthesis of cryptic natural products was investigated. Sponge-derived actinomycete Micromonospora sp. UA17 was co-cultured using liquid fermentation with two mycolic acid-containing actinomycetes (Gordonia sp. UA19 and Nocardia sp. UA 23), or supplemented with pure mycolic acid. LC-HRESIMS data were analyzed to compare natural production across all crude extracts. Micromonospora sp. UA17 was rich with isotetracenone, indolocarbazole, and anthracycline analogs. Some co-culture extracts showed metabolites such as a chlorocardicin, neocopiamycin A, and chicamycin B that were not found in the respective monocultures, suggesting a mycolic acid effect on the induction of cryptic natural product biosynthetic pathways. The antibacterial, antifungal, and antiparasitic activities for the different cultures extracts were also tested.

25 August 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
TATarfah Al-Warhi
Tarfah Al-Warhi
Abeer H. ElmaidomyAbeer H. Elmaidomy
Abeer H. Elmaidomy
SASherif Ali
Sherif Ali
DADalia H. Abu-Baih
Dalia H. Abu-Baih
Samy SelimSamy Selim
Samy Selim
Usama AbdelmohsenUsama Abdelmohsen
Usama Abdelmohsen
Olea europaea L. Cv. Arbequina (OEA) (Oleaceae) is an olive variety species that has received little attention. Besides our previous work for the chemical profiling of OEA leaves using LC–HRESIMS, an additional 23 compounds are identified. An excision wound model is used to measure wound healing action. Wounds are provided with OEA (2% w/v) or MEBO® cream (marketed treatment). The wound closure rate related to vehicle-treated wounds is significantly increased by OEA. Comparing to vehicle wound tissues, significant levels of TGF-β in OEA and MEBO® (p < 0.05) are displayed by gene expression patterns, with the most significant levels in OEA-treated wounds. Proinflammatory TNF-α and IL-1β levels are substantially reduced in OEA-treated wounds. The capability of several lignan-related compounds to interact with MMP-1 is revealed by extensive in silico investigation of the major OEA compounds (i.e., inverse docking, molecular dynamics simulation, and ΔG calculation), and their role in the wound-healing process is also characterized. The potential of OEA as a potent MMP-1 inhibitor is shown in subsequent in vitro testing (IC50 = 88.0 ± 0.1 nM). In conclusion, OEA is introduced as an interesting therapeutic candidate that can effectively manage wound healing because of its anti-inflammatory and antioxidant properties.